When a group of FDA advisors recently assessed a heart device made by Abbott, the agency didn’t disclose that most of them had received payments from the company.
Related Posts
Senate investigating whether ER care has been harmed by growing role of private-equity firms
The Senate has asked three private-equity firms fo
